Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.

Pechlivani, Nikoletta; Kearney, Katherine J; Ajjan, Ramzi A

Pechlivani, Nikoletta; Kearney, Katherine J; Ajjan, Ramzi A.

Pechlivani N; Division of Cardiovascular & Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds LS2 9JT, UK.
Kearney KJ; Division of Cardiovascular & Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds LS2 9JT, UK.
Ajjan RA; Division of Cardiovascular & Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds LS2 9JT, UK.

Int J Mol Sci ; 22(22)2021 Nov 21.

Article en En | MEDLINE | ID: mdl-34830419

Asunto(s)

Carboxipeptidasa B2/genética; Fibrinógeno/genética; Hemorragia/terapia; alfa 2-Antiplasmina/genética; Anticoagulantes; Complemento C3/genética; Fibrinólisis/genética; Hemorragia/genética; Humanos; Inhibidor 2 de Activador Plasminogénico/genética; Trombosis/genética

Palabras clave

antifibrinolytic proteins; bleeding; fibrinogen; therapeutics; thrombosis

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrinógeno / Alfa 2-Antiplasmina / Carboxipeptidasa B2 / Hemorragia Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google